Skip to main content

JOINT Corp

corporate_fare Company Profile

JOINT Corp

JYNT·NASDAQ·Real Estate & Construction·CIK 0001612630

The Joint Corp. is a franchisor and operator of chiropractic clinics, focused on providing routine and affordable chiropractic care through a private pay, non-insurance, cash-based model. The company aims to be a leading provider and the most recognized brand in the chiropractic industry. In 2025, the company delivered over 14.4 million patient visits, generating over $532.4 million in system-wide sales. This is a decrease from 14.7 million patient visits and $530.3 million in system-wide sales in 2024. The Joint Corp. operates a highly franchised network of modern, consumer-friendly clinics that employ licensed chiropractors. This model allows the company to price its services below most competitors and typical insurance co-payment levels. Since acquiring its predecessor in March 2010, the company has expanded from eight to 960 clinics in operation as of December 31, 2025. As of the same date, franchisees owned or managed 885 clinics, and the company owned or managed 75 clinics. Additionally, 82 franchise licenses were sold but not yet developed, and there were 57 letters of intent for 57 future clinic licenses. The company collects a royalty of 7.0% of gross sales from franchised clinics, remitting a 3.0% royalty to regional developers for franchises within their protected territories. A national marketing fee of 2.0% of gross sales is also collected from all franchised clinics. The company's expansion is focused on key markets throughout North America.

JOINT Corp (NASDAQ:JYNT) is a publicly traded company in the Real Estate & Construction sector. Wiseek monitors JYNT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • 10% Owner Charles Jobson Buys $1.27M in JOINT Corp Stock
  • JOINT Corp Secures Default Waiver, Extends Credit, Reports Mixed Q1 Results Amid Refranchising
  • JOINT Corp Advances Pure-Play Franchisor Strategy with Partial Closing of 45-Clinic Sale
  • JOINT Corp Sells 45 Clinics for $2.3M in Strategic Refranchising Move
  • JOINT Corp Reports Strong 2025 Profitability, $11.3M Share Repurchase, and Strategic Refranchising Progress

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$54.9M
Net Income
$2.91M
Diluted EPS
$0.19
Op. Cash Flow
$1.84M
Free Cash Flow
$334.72K
Gross Profit
$43.67M
Operating Income
-$913.38K
Cash & Equivalents
$23.6M
Debt / Equity
0.00×
Net Margin
5.3%
Shares Outstanding
14.14M sh
Source: 10-K · filed 2026-03-12 · accession 0001612630-26-000022
Browse all tickers starting with J →
$9.58
52-week range · as of 2026-05-14 $7.5 – $13.47
Market cap
$136.57M
Volume
134.6K (1.5× avg)
3-mo avg 91.3K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed JYNT - Latest Insights

JYNT
May 14, 2026, 6:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.32
Real-time Price: $9.58 info
Change: +$1.26 (+15%) info
Market Cap: $136.567M info
JYNT
May 07, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.67
Real-time Price: $9.58 info
Change: +$0.910 (+10%) info
Market Cap: $136.567M info
JYNT
May 01, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.90
Real-time Price: $9.58 info
Change: +$0.680 (+8%) info
Market Cap: $136.567M info
JYNT
Apr 24, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.02
Real-time Price: $9.58 info
Change: +$0.560 (+6%) info
Market Cap: $136.567M info
JYNT
Apr 07, 2026, 4:07 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $8.91
Real-time Price: $9.58 info
Change: +$0.670 (+8%) info
Market Cap: $136.567M info
JYNT
Mar 16, 2026, 7:07 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $9.58 info
Change: +$1.08 (+13%) info
Market Cap: $136.567M info
JYNT
Mar 12, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.21
Real-time Price: $9.58 info
Change: +$1.37 (+17%) info
Market Cap: $136.567M info
JYNT
Jan 09, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $9.58 info
Change: +$0.340 (+4%) info
Market Cap: $136.567M info
JYNT
Jan 07, 2026, 6:17 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $8.83
Real-time Price: $9.58 info
Change: +$0.750 (+8%) info
Market Cap: $136.567M info